SKYE

Conviction 9HealthcareScan · Thu, Jun 25, 2026

SKYE$0.6983+2.84%

ResistanceSupportVol 14

Vol MA14 154.07K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Skye Bioscience, Inc.PHARMACEUTICAL PREPARATIONSwww.skyebioscience.com ↗

Price0.6983

Change+2.84%

Gap+2.25%

Rel volume0.21×

Avg volume184.59K

Avg $ vol138.75K

SMA 200.7459

SMA 500.8043

SMA 2001.27

Price vs 50-13.18%

Price vs 200-44.81%

MA stackbearish

50/200 cross—

Supertrenddown · 0.8634

RSI (14)42

MACD hist-0.01

MACD crossbear · 7d

Stoch %K / %D16 / 10

ADX (14)15

+DI / −DI15 / 21

RSI divergenceBullish

MACD divergenceBullish

ATR %+8.50%

ADR %7.59%

52w high4.75

52w low0.5770

From 52w high-85.30%

Above 52w low+21.02%

New 52w highNo

SqueezeOn · 13d

Bollinger width22.36%

%B0.21

Donchian pos14.89%

Donchian high0.8600

Donchian low0.6700

AVWAP (52w high)1.99

vs AVWAP high-64.99%

AVWAP (52w low)0.7978

vs AVWAP low-12.47%

OBV trendDown

Chaikin MF (20)-0.20

Today vs 20d0.21×

Avg vol (14d)154.07K

Avg vol (20d)184.59K

Avg $ vol (20d)138.75K

Market cap24.54M

RS 3m (vs SPY)-3.62%

RS 6m (vs SPY)-34.73%

RS line new highNo

Trend template0/8

Technical rank14.6

1 week-1.86%

1 month-15.06%

3 months+11.76%

6 months-24.10%

1 year-80.71%

YTD-20.49%

P/E-0.44

P/B2.72

P/S—

P/FCF-0.57

EPS-1.41

Div yield—

ROE-620.57%

ROA-288.02%

Debt/Eq0.01

Current1.78

EV/EBITDA-0.29

Gross margin—

Net margin—

Rev growth—

EPS growth-110.50%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value16.51M

Revenue—

Net income-12.51M

Gross profit—

Free cash flow-43.07M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out35.14M

Employees12

ListedMon, Feb 24, 2014

Free float21.44M

Float %61.0%

Short interest1.13M

Days to cover6.6d

Short volume56.5%

Squeeze score47 / 100

Next earningsThu, Aug 6, 2026 (42d)

EPS forecast−$0.29 · 3 est

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction9 / 100

Pattern quality—

Tech rank14.6 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.9299

Support0.6880

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SKYE

All disclosures →

No recent disclosed trades by Congress in SKYE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SKYE

No recent insider (Form 4) filings in SKYE. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in SKYE · 1 recent

EDGAR →

8-K8-KTue, Jun 23, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.